Abstract
Dislocation of the TMJ affects a wide demographic (up to 5% of the population) and can be attributed to a wide variety of causes including excessive mouth opening (e.g. yawning, vomiting, seizure), trauma (e.g. flexion-extension injury to the mandible, intubation, endoscopy, dental extraction), connective tissue disorders (e.g. Ehlers-Danlos syndrome, Marfan’s syndrome) and psychogenic causes (e.g. habitual dislocation, tardive dyskinesia) as possibly the majority of cases [1]. Single episodes of TMJ dislocation are often managed by manual reduction techniques (discussed elsewhere in this text) and require no further intervention. The terms “chronic”, “chronic recurrent” and “habitual” are interchangeable and used for cases in which repeated episodes of dislocation occur [2]. Other authors distinguish “acute”, “chronic” (i.e. persistently dislocated) and “recurrent”. Recurrent dislocations can be particularly troublesome and are the subject of discussion in the current chapter, which deals with conservative interventions to address these problems.
References
Chhabra S, Chhabra N, Gupta P Jr. Recurrent mandibular dislocation in geriatric patients: treatment and prevention by a simple and non-invasive technique. J Maxillofac Oral Surg. 2015;14(Suppl 1):S231–4.
Guven O. Management of chronic recurrent temporomandibular joint dislocations: a retrospective study. J Craniomaxillofac Surg. 2009;37(1):24–9.
Matsushita K, Abe T, Fujiwara T. OK-432 (Picibanil) sclerotherapy for recurrent dislocation of the temporomandibular joint in elderly edentulous patients: case reports. Br J Oral Maxillofac Surg. 2007;45:511–3.
Ziegler CM, Haag C, Muhling J. Treatment of recurrent temporomandibular joint dislocation with intramuscular botulinum toxin injection. Clin Oral Investig. 2003;7:52–5.
Coser R, da Silveira H, Medeiros P, Ritto FG. Autologous blood injection for the treatment of recurrent mandibular dislocation. Int J Oral Maxillofac Surg. 2015;44:1034–7.
Machon V, Abramowicz S, Paska J, Dolwick MF. Autologous blood injection for the treatment of chronic recurrent temporomandibular joint dislocation. J Oral Maxillofac Surg. 2009;67:114–9.
Yoshida H, Oshiro N, Gotoh M, et al. Minimum invasive treatment of habitual temporomandibular joint dislocation by autologous blood injection around the temporomandibular joint capsule. Jpn J Oral Diag/Oral Med. 2013;26:87–92.
Bayoumi AM, Al-Sebaei MO, Mohamed KM, et al. Arthrocentesis followed by intra-articular autologous blood injection for the treatment of recurrent temporomandibular joint dislocation. Int J Oral Maxillofac Surg. 2014;43(10):1224–8.
Gulses A, Bayar GR, Aydintug YS, et al. Histological evaluation of the changes in temporomandibular joint capsule and retrodiscal ligaments following autologous blood injection. J Craniomaxillofac Surg. 2013;41:316–20.
Oshiro N, Yoshida H, Uemura M, et al. Analysis of MRI findings in minimum invasive treatment for habitual temporomandibular joint dislocation by autologous blood injection around the temporomandibular joint capsule. J Craniomaxillofac Surg. 2014;42:1486–90.
Hooiveld M, Roosendaal G, Vianen M, et al. Blood-induced joint damage: long-term effects in vitro and in vivo. J Rheumatol. 2003;30:339–44.
Hooiveld M, Roosendaal G, Wenting M, et al. Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol. 2003;162(3):943–51.
Aquilina P, Vickers R, McKellar G. Reduction of chronic bilateral temporomandibular joint dislocation with intermaxillary fixation and botulinum toxin A. Br J Oral Maxillofac Surg. 2004;42(3):272–3.
Hegab AF. Treatment of chronic recurrent dislocation of the temporomandibular joint with injection of autologous blood alone, intermaxillary fixation alone, or both together: a prospective, randomized, controlled clinical trial. Br J Oral Maxillofac Surg. 2013;51(8):813–7.
Terakado N, Shintani S, Nakahara Y, et al. Conservative treatment of prolonged bilateral mandibular dislocation with the help of an intermaxillary fixation screw. Br J Oral Maxillofac Surg. 2006;44:62–3.
Pradhan L, Jaisani MR, Sagtani A, Win A. Conservative management of chronic TMJ dislocation: an old technique revived. J Oral Maxillofac Surg. 2015;14(Suppl1):267–70.
Vasquez Bouso O, Forteza Gonzalez G, Mommsen J, et al. Neurogenic temporomandibular joint dislocation treatment with botulinum toxin: report of 4 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:e33–7.
Daelen B, Thorwirth V, Koch A. Neurogenic temporomandibular joint dislocation. Definition and therapy with botulinum toxin. Nervenarzt. 1997;68(4):346–50.
Daelen B, Thorwirth V, Koch A. Treatment of recurrent dislocation of the temporomandibular joint with type A botulinum toxin. Int J Oral Maxillofac Surg. 1997;26:458–60.
Martinez-Perez D, Garcia Ruiz-Espiga P. Recurrent temporomandibular joint dislocation treated with botulinum toxin: report of 3 cases. J Oral Maxillofac Surg. 2004;62:244–6.
Blitzer A, Brin M, Greene PE, et al. Botulinum toxin injection for the treatment of orofacial dystonia. Ann Otol Rhinol Laryngol. 1989;98:93.
Mynsberge M, Heidelman J, Bennett JEMG. guided lateral pterygoid muscle Botox-A injection for chronic temporomandibular joint dislocation: 2 patient case report. J Indiana Dent Assoc. 2014;93(1):22–6.
Moore AP, Wood GD. Medical treatment of recurrent temporomandibular joint dislocation using botulinum toxin A. Br Dent J. 1997;183:415–7.
McKelvey LE. Sclerosing solution in the treatment of chronic subluxation of the temporomandibular joint. J Oral Surg (Chic). 1950;8(3):225–36.
Zhou Q, Zheng JW, Mai HM, et al. Treatment guidelines of lymphatic malformations of the head and neck. Oral Oncol. 2011;47(12):1105–9.
Zhou H, Hu K, Ding Y. Modified dextrose prolotherapy for recurrent temporomandibular joint dislocation. Br J Oral Maxillofac Surg. 2014;52:63–6.
Refai H, Altahan O, Elsharkawy R. The efficacy of dextrose prolotherapy for temporomandibular joint hypermobility: a preliminary prospective, randomized, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Surg. 2011;69(12):2962–70.
Yap AU, Dworkin SF, Chua EK, et al. Prevalence of temporomandibular disorder subtypes, psychologic distress, and psychosocial dysfunction in Asian patients. J Orofac Pain. 2003;17(1):21–8.
Yap AU, Tan KB, Chua EK, Tan HH. Depression and somatization in patients with temporomandibular disorders. J Prosthet Dent. 2002;88(5):479–84.
Kodama M, Fujiwara M. Risperidone-induced dislocation of the temporomandibular joint. J Clin Psychiatry. 2012;73(2):176.
Ibrahim ZY, Brooks EF. Neuroleptic-induced bilateral temporomandibular joint dislocation. Am J Psychiatry. 1996;153(2):293–4.
O’Connor M, Rooney MD, Nienaber CP. Neuroleptic-induced dislocation of the jaw. Br J Psychiatry. 1992;161:281–2.
Johansson AK, Johansson A, Unell L, et al. Eating disorders and signs and symptoms of temporomandibular disorders: a matched case-control study. Swed Dent J. 2010;34(3):139–47.
Emodi-Perlman A, Yoffe T, Rosenberg N, et al. Prevalence of psychologic, dental and temporomandibular signs and symptoms among chronic eating disorder patients: a comparative control study. J Orofac Pain. 2008;22(3):201–8.
Blyer SM, Casino A, Reebye UN. Munchausen syndrome: a case report of suspected self-induced temporomandibular joint subluxation. J Oral Maxillofac Surg. 2007;65(11):2371–4.
Asher R. Munchausen’s syndrome. Lancet. 1951;1:339.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Elledge, R.O.C., Speculand, B. (2018). Conservative Management Options for Dislocation of the Temporomandibular Joint. In: Matthews, N. (eds) Dislocation of the Temporomandibular Joint. Springer, Cham. https://doi.org/10.1007/978-3-319-62652-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-62652-9_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62651-2
Online ISBN: 978-3-319-62652-9
eBook Packages: MedicineMedicine (R0)